TrialBMC nephrology2025
Twice against thrice-weekly hemodialysis (TATH): a multicenter nonrandomized trial.
Mabel Aoun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
TrialBMC nephrology2025
Mabel Aoun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.